Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations [Phase 1]
Phase 1 trial results evaluate BAY86-9596 as a PET tracer for diagnostic imaging across cancer and inflammatory conditions. The study report…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer [Phase 2]
A Phase II trial evaluating Genexol-PM in combination with Gemcitabine for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC)
This clinical trial update notes the completion of a study evaluating preoperative endobronchial ultrasound (EBUS) in non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab [Phase 2]
This Phase 2 trial evaluated a regimen of radiation therapy with bevacizumab, paclitaxel, and carboplatin in patients with unresectable Stag…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating vorinostat in combination with palliative radiotherapy for non-small cell lung cancer has completed with r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients [Phase 1]
Phase 1 trial evaluating the safety and tolerability of a continuous intravenous infusion of Endostar combined with pemetrexed and carboplat…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial of Bortezomib in patients with advanced non-small cell lung cancer was terminated. The update notes the trial status and the c…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 [Phase 2]
A Phase 2 trial evaluated trastuzumab for HER2-overexpressing stage IIIB or stage IV non-small cell lung cancer; the study status is complet…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer [NA]
This NCI-sponsored clinical trial evaluating EF5 and Motexafin Lutetium for detecting tumor cells in patients with abdominal cancers or non-…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed disodium with carboplatin and radiation therapy, with or without cetuximab, in stage III non-small cell …
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers [Phase 3]
This document reports on a completed Phase 3 trial evaluating PET imaging in potentially surgically resectable non-small cell lung cancer. I…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Comparison of Sequencing and PNA Clamping of EGFR Gene in Patients With Non-Small Cell Type Lung Cancer
This clinical trial update compares sequencing and PNA clamping methods for EGFR gene testing in patients with non-small cell lung cancer, s…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer [Phase 1]
Pfizer conducted a Phase 1 trial of erlotinib with or without the investigational agent PF-02341066 in patients with non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer [NA]
This document summarizes a completed clinical trial evaluating gefitinib for metastatic or unresectable head and neck cancer and non-small c…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 randomized trial in non-small cell lung cancer compared PR-104 alone to PR-104 with docetaxel and was terminated with results post…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]
Clinical trial updates show Erlotinib tested in patients with advanced Non-small Cell Lung Cancer, Ovarian Epithelial Cancer, and Head and N…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 clinical trial update announcing completion of a study of the monoclonal antibody ABX-EGF in patients with multiple cancers, inclu…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. [Phase 1]
This clinical trial update reports the termination of a Phase I study of AZD1480 in patients with advanced solid malignancies and advanced h…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Iressa Expanded Access Program (EAP) [Phase 3]
Update on AstraZeneca's Iressa (gefitinib) Expanded Access Program in Phase 3 for non-small-cell lung cancer, including metastatic disease, …
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer [Phase 2]
Pfizer-sponsored Phase 2 trial evaluating AG-013736 with cisplatin and gemcitabine in patients with squamous non-small cell lung cancer; the…
-
CLINICAL_TRIALS trial_result · 2013-01-01Clinical Trial Update: A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer [Phase 3]
Phase 3 trial comparing aflibercept plus docetaxel versus placebo plus docetaxel in second-line locally advanced or metastatic non-small cel…
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma [Phase 2]
A Phase 2 trial evaluated docetaxel and gemcitabine with Filgrastim-SD/01 support in patients with advanced non-small cell lung cancer; the …
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating cisplatin and docetaxel with or without radiation therapy in newly diagnosed stage III non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2012-12-25Clinical Trial Update: S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating docetaxel and cetuximab with radiation therapy in stage III non-small cell lung cancer was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III [Phase 2]
This clinical trial update reports the completion of a Phase II study evaluating docetaxel plus cisplatin for stage III non-small cell lung …